Home/Immix Biopharma/Michael Grabow
MG

Michael Grabow

Chief Commercial Officer

Immix Biopharma

Therapeutic Areas

Immix Biopharma Pipeline

DrugIndicationPhase
NXC-201Relapsed/Refractory AL AmyloidosisPhase 1b/2a